Status | Study |
Recruiting |
Study Name: Bucillamine Phase 2 Trial in Patients With Cystinuria Condition: Cystinuria Date: 2016-10-19 Interventions: Drug: Bucillamine Thiol donor which results in a cysteine-bucillamine complex for removing excess cystei |
Not yet recruiting |
Study Name: Lipoic Acid Supplement for Cystine Stone Condition: Cystinuria Date: 2016-09-20 Interventions: Dietary Supplement: Alpha lipoic acid |
Enrolling by invitation |
Study Name: Sulfamethoxazole for the Treatment of Primary PREPL Deficiency Condition: Hypotonia Cystinuria Syndrome Isolated PREPL Deficiency Date: 2015-10-07 Interventions: Drug: Sulfamethoxazole 60 mg sulfamethoxazole per kg bodyweight (maximal of 3g) divided in 2 doses per d |
Not yet recruiting |
Study Name: TCUPS- Tolvaptan Use in Cyctinuria and Urolithiasis: A Pilot Study Condition: Cystinuria Date: 2015-07-21 Interventions: Drug: Tolvaptan |
Completed |
Study Name: Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome) Condition: Gitelman Syndrome Potassium Depletion Date: 2014-10-29 Interventions: Dietary Supplement: Potassium depletion Healthy subjects will be submitted twice at 15-30 day interval, |
Active, not recruiting |
Study Name: Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria Condition: Cystinuria Date: 2014-04-24 Interventions: Drug: CBTD 0-3 gm Oral CBTD 0-3 gm dose/day for 7 days, dose escalation |
Completed |
Study Name: Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter Condition: Heterozygous Carriers of Gitelman Syndrome Date: 2013-12-18 Interventions: Procedure: Samplings of blood Procedure: S |
Completed |
Study Name: Review of Kidney Biopsies of Dent Disease Patients Condition: Dent Disease Date: 2013-12-06 Interventions: Procedure: Renal Biopsy Other Name: All patients in the Dent Disease Registry with a previous renal biop |
Recruiting |
Study Name: Role Of Phosphorus And FGF 23 In Patients With Dent Disease Condition: Dent Disease Date: 2013-12-06 Interventions: Drug: Phosphorus Supplement 250 mg po qid Other Name |
Active, not recruiting |
Study Name: Cystine Capacity Clinical Study (CysCap) Condition: Cystinuria Date: 2013-06-04 |